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IMPORTANCE Despite the prevalence and the functional, psychological, and economic impact
of chronic pain, few intervention studies of treatment of chronic pain in veterans have been
performed.
OBJECTIVE To determine whether a stepped-care intervention is more effective than usual
care, as hypothesized, in reducing pain-related disability, pain interference, and pain severity.
DESIGN, SETTING, AND PARTICIPANTS Weperformed a randomized clinical trial comparing
stepped care with usual care for chronic pain. We enrolled 241 veterans fromOperation
Enduring Freedom, Operation Iraqi Freedom, and Operation NewDawnwith chronic
(>3 months) and disabling (RolandMorris Disability Scale score,7) musculoskeletal pain of
the cervical or lumbar spine or extremities (shoulders, knees, and hips) in the Evaluation of
Stepped Care for Chronic Pain (ESCAPE) trial from December 20, 2007, through June 30,
2011. The 9-month follow-up was completed by April 2012. Patients received treatment at a
postdeployment clinic and 5 general medicine clinics at a Veterans Affairs medical center.
INTERVENTIONS Step 1 included 12 weeks of analgesic treatment and optimization according
to an algorithm coupled with pain self-management strategies; step 2, 12 weeks of cognitive
behavioral therapy. All intervention aspects were delivered by nurse care managers.
MAIN OUTCOMES ANDMEASURES Pain-related disability (RolandMorris Disability Scale), pain
interference (Brief Pain Inventory), and pain severity (Graded Chronic Pain Scale).
RESULTS The primary analysis included 121 patients receiving the stepped-care intervention
and 120 patients receiving usual care. At 9months, the mean decrease from baseline in the
RolandMorris Disability Scale score was 1.7 (95% CI, −2.6 to −0.9) points in the usual care
group and 3.7 (95% CI, −4.5 to −2.8) points in the intervention group (between-group
difference, −1.9 [95% CI, −3.2 to −0.7] points; P = .002). Themean decrease from baseline in
the Pain Interference subscale score of the Brief Pain Inventory was 0.9 points in the usual
care group and 1.7 points in the intervention group (between-group difference, −0.8 [95% CI,
−1.3 to −0.3] points; P = .003). The Graded Chronic Pain Scale severity score was reduced by
4.5 points in the usual care group and 11.1 points in the intervention group (between-group
difference, −6.6 [95% CI, −10.5 to −2.7] points; P = .001).
CONCLUSIONS AND RELEVANCE A stepped-care intervention that combined analgesics,
self-management strategies, and brief cognitive behavioral therapy resulted in statistically
significant reductions in pain-related disability, pain interference, and pain severity in
veterans with chronic musculoskeletal pain.
TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00386243
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C hronic pain is a critical health problem that affects ap-proximately 100millionUS adults.1 Chronic pain coststhe United States an estimated $635 billion each year
in medical treatment and lost productivity1 and is the most
common cause of disability.2 Chronic pain is frequently ac-
companied by mental health disorders that complicate
treatment.3 The deleterious effects of chronic pain on quality
of life and function are well known.4
Chronic pain is a critical health problem among veter-
ans. Pain was the most frequently reported symptom in vet-
erans of the Persian Gulf War5 and ranged in prevalence
from 40% to 50% among veterans of Operation Enduring
Freedom, Operation Iraqi Freedom, and Operation New
Dawn (OEF/OIF/OND).6,7 The Veterans Affairs (VA) pain
management strategy8 was initiated in 1998 and established
pain management as a national priority. Despite this effort,
no intervention studies to treat chronic pain in veterans of
the Iraq and Afghanistan conflicts have been reported, to
our knowledge.
Theabsenceof studies is concerningbecause chronicpain
may prove evenmore disabling in veterans of recent conflicts
than in veterans of previous eras owing to thehigh combat in-
tensity of theOEF/OIF/OND conflicts and an increased preva-
lenceof comorbidities, suchas anxiety anddepression.9Given
theprevalenceofpain, associatedmorbidity, and relatedcosts,
enormous challenges lie ahead for the VA. Other health care
systems also will be challenged as veterans return frommili-
tary service and seek care.
Numerous studies have documented inadequate pain
management.10,11 Although several guidelines exist,12-14 evi-
dence suggestsmodest effectiveness of the current pain treat-
ments. Painmanagement is complexowing to the interplayof
multiple biological, psychological, and social factors that con-
tribute to chronic pain. This complexity often leads to a fail-
ure to respond well to single treatments, requiring a multi-
modal, multidisciplinary treatment approach.15 Although
multidisciplinarypainclinicshavebeenshownto improvepain
outcomes,16 these clinics are not widely available because of
fiscal constraints and reimbursement issues.17
For patients with chronic pain, self-management pro-
gramshaveprovedeffective.A systematic reviewbyNewman
et al18 found strong evidence that self-management strate-
gies are effective for lowbackandosteoarthritis pain. Further-
more, pain outcomes may depend more on effective self-
management than on other treatments.19
Cognitive behavioral therapy (CBT) is a skills-based treat-
ment that teaches patients to identify and change maladap-
tive thoughts and behaviors and to replace them with more
helpful thoughts andbehaviors. Strongevidence fromnumer-
ous studies supports the benefits of CBT for several pain
conditions,20 including chronic pain.21
The stepped-care model, which is validated for the
management of low back pain in primary care,22 guided the
Evaluation of Stepped Care for Chronic Pain (ESCAPE) trial.
The ESCAPE trial tested an intervention involving 12 weeks
of analgesic therapy optimization according to an algorithm
coupled with pain self-management strategies (step 1) fol-
lowed by 12 weeks of CBT (step 2). The primary aim was to
estimate the effectiveness of the intervention during a
9-month period in veterans of the Afghanistan (OEF) and
Iraq (OIF/OND) conflicts who had chronic and disabling
musculoskeletal pain.
Methods
Study Setting and Sample
From December 20, 2007, through June 30, 2011, we re-
cruited participants from patients at a postdeployment clinic
and 5 generalmedicine clinics at the sameVAmedical center.
Potential participants were identified through the VA’s elec-
tronic medical record to create a master list of veterans who,
within thepreceding6months, reportedat leastmoderatepain
(painscore,≥4), according to thescale routinelyused inVAclin-
ics (0 indicates no pain; 10, worst pain imaginable).8 The in-
stitutional review board of Indiana University and the re-
searchcommitteeof theRichardL.RoudebushVeteransAffairs
MedicalCenter, Indianapolis, approved this study, and the trial
was monitored by an independent data and safety monitor-
ingboard. The full studyprotocol canbe found in the trial pro-
tocol in Supplement 1.
Patients were included if they were OEF/OIF/OND veter-
ans, if they self-reported chronic pain (>3 months’ duration)
of the cervical or lumbar spine or an extremity (hip, knee, or
shoulder), and if pain was at least moderately disabling (de-
finedasaRolandMorrisDisabilityScale [RMDS]scoreof≥7)23,24
at the initial visit. Individuals were excluded if they had se-
vere medical conditions that might limit study participation,
active psychosis, schizophrenia, current alcohol or substance
dependence, active suicidal ideation, prior or pending back
surgery, or pregnancy. All enrolled patients gave written
informed consent.
Randomization and BlindedOutcome Assessments
After the baseline interview, eligible participants were block
randomized in groupsof 8 to the stepped-care interventionor
to the usual care arm. Randomization lists were generated by
computer, and treatment assignmentswere supplied in sealed
opaqueenvelopes.Afterobtainingpatientconsentandcomple-
tion of a baseline assessment, the project manager (C.S.) re-
vealed the randomization assignment for each patient by op-
eningthenextenvelope insequence.Allbaselineandfollow-up
assessments were conducted by a trained research assistant
(A.F.) who was blinded to the treatment allocation.
Outcome Assessments
Data were collected at baseline and 3, 6, and 9 months after
randomization.Theassessment interviewswere conducted in
person, by telephone, or via mail. The assessments were in-
formedbyrecommendationsof the InitiativeonMethods,Mea-
surement andPainAssessment inClinical Trials (IMMPACT).25
The primary study outcomewas pain-related disability as as-
sessed by the 24-itemRMDS,23,24which has been validated in
patients with low back pain and other chronic pain condi-
tions. This scale is scored from 0 to 24; higher scores repre-
sentmore severepain-relateddisability. In lowbackpain trials,
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Patrick et al26 and Bombardier et al27 suggested a minimum
clinically significantdifference inRMDSscoresof 2 to 3points.
Furthermore, Jordanetal28 identifieda30%decreaseasaclini-
cally meaningful improvement.
Twoother primarypainoutcomes assessed includedpain
interference and pain severity. Pain interference was as-
sessed by the Pain Interference subscale from the Brief Pain
Inventory (BPI).29 The BPI Pain Interference subscale has 7
items that rate howpain interfereswithmood, physical activ-
ity, work, social activity, relations with others, sleep, and en-
joymentof life (range,0-10).Higher scores indicategreaterpain
interference. We calculated the mean of the 7 item scores for
an overall Pain Interference score, and a 1- to 2-point change
was considered clinically important, with a decrease consid-
ered improvement. Pain severitywasmeasured by the 7-item
GradedChronic Pain Scale,30which rates patients’ pain sever-
ity ona scale of 0 to 100,withhigher scores representingmore
severe pain. Further research is needed to assess clinically
meaningful cut points.
Intervention
The intervention was delivered by 2 nurse care managers
(NCMs) (which includedC.K.) trained in all treatment compo-
nents, including optimization of analgesic treatment, self-
management strategies, andCBT. TheNCMsmetweeklywith
physician investigators (M.J.B. andD.A.) andasupervisingpsy-
chologist (L.W.D.) to review care of the intervention group, a
model of case supervision implemented inprevious trials.31,32
The protocol called for biweekly telephone contacts between
thepatients andNCMs for a total of 12 contacts during the trial
period. Several procedureswere implemented toensure treat-
ment fidelity, including extensive training, observation, au-
diotaping, and feedback after treatment sessions. To en-
hance the reproducibility of the intervention, we used a
manualized and algorithmic approach in the context of a care
management delivery model.
Step 1
In clinical practice, analgesics are themost common andprag-
matic approach to treating pain. Therefore, step 1 consisted of
optimizationofanalgesictherapyfor12weeksusinganevidence-
basedalgorithm33 (outlined inTable 1).Weoperationally classi-
fied analgesics into the following 8 categories: (1) first-line
analgesics; (2) other nonsteroidal anti-inflammatory drugs;
(3) topicalanalgesics; (4)gabapentinoids; (5) tricyclicantidepres-
sants and cyclobenzaprine hydrochloride; (6) tramadol hydro-
chloride; (7) short-acting opioids; and (8) long-acting opioids.
At the study baseline, the NCMs obtained a comprehen-
sive history of previous pain treatments. This treatment his-
tory included previous use of analgesics, including duration
anddosing, todeterminewhether an adequate treatment trial
hadbeencompleted. If inadequatedosage, scheduling,or treat-
ment adherence had been a problem, a trial of the previously
tried analgesic with appropriate dosing and scheduling was
recommended.
TheNCMsfollowedanalgorithmdevelopedbytheESCAPE
investigators33 andconducted follow-upcalls toassesschanges
in pain severity and interference, global improvement, pa-
tient desire for treatment change, and treatment adherence.
If bothersomeadverseeffects emerged,patients receivedadif-
ferent analgesic treatment. Treatment responsewas assessed
every 2 weeks, and ongoing care was discussed during case
managementmeetings. Prescriptions were entered by a phy-
sician-investigator (M.J.B.), andall studymedicationsweredis-
pensed through themedical centerpharmacy.A researchphar-
macist oversawmedication dispensing.
Because analgesicsmaynot relievepain sufficientlywhen
used alone, this intervention step also involved teaching pa-
tients pain self-management strategies. In conjunction with
analgesic treatment, the intervention group received educa-
tion about common treatments and the natural history of
chronic pain. The NCMs encouraged all patients to minimize
bed rest, return to normal activities as soon as possible, and
perform recommended stretching and strengthening exer-
cises, including walking.
Patients were also provided a menu of self-management
strategies to learn and use to help to manage their pain. The
menu of additional strategies included goal setting, problem
solving, positive self-talk, relaxation techniques, behavioral
plans, and communication with their primary care physi-
cians. The NCMs delivered the self-management strategies
using a standardized protocol.
Becauseweexpectedmany studypatientswouldhave co-
existing mental health conditions, the NCMs regularly as-
sessed fordepressionandanxiety symptomsduringeachstep.
Patients found to have comorbidmajor depression, posttrau-
matic stress disorder, or severe anxiety received a referral to a
mental health practitioner.
Step 2
All patients proceeded to step 2 immediately after comple-
tion of step 1. Analgesic therapy and self-management strat-
egies started during step 1 were continued.
Table 1. ESCAPE Trial Step 1 Analgesic Algorithm
Category Analgesic
First line Acetaminophen and naproxen
Other NSAIDs Ibuprofen, meloxicam, etodolac, diclofenac, and
salsalate
Topical analgesics For example, capsaicin cream, 0.025% or 0.075%
Gabapentinoids Gabapentin and pregabalin
Tricyclic
antidepressants and
cyclobenzaprine
hydrochloride
Nortriptyline hydrochloride and amitriptyline
hydrochloride
Tramadol
hydrochloridea
Tramadol
Short-acting opioids Combined hydrocodone bitartrate and
acetaminophen, combined oxycodone
hydrochloride and acetaminophen, and immediate-
release oxycodone and morphine
Long-acting opioids Sustained-release morphine and methadone
hydrochloride
Abbreviations: ESCAPE, Evaluation of Stepped Care for Chronic Pain;
NSAIDs, nonsteroidal anti-inflammatory drugs.
a Included in its own class as a weak opioid or a combination opioid and
norepinephrine reuptake inhibitor.
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To complement the behavioral focus of pain self-
management in step 1,we adapted aCBTprogram.34 This pro-
gramwas based on the CBT concept that thoughts affect feel-
ings that, in turn, affect behaviors. The CBT step consisted of
6 individual sessions delivered by telephone. Biweekly ses-
sions lasted approximately 45 minutes and involved discus-
sions of thoughts and feelings about pain, past treatments for
pain, identification of barriers to reducing functional limita-
tionsandpainseverity, andcognitive restructuringafter coach-
ing from a psychologist. The NCMs helped veterans to iden-
tifymaladaptive thoughts, including inaccurate interpretations
of pain and its impact. Patientswere taught to examine the ac-
curacy andusefulness of these thoughts and to developmore
adaptive cognitions. At the end of each session, home prac-
tice was assigned to apply the lessons learned.
Usual Care
Patients randomized to usual care received educational hand-
outsonmusculoskeletalpain.Duringthetrial,patientswere fol-
lowedupbytheirtreatingphysicianforallmedicalcare.Thiscare
includedcontinuationofmedications, clinicvisits, specialty re-
ferrals, andothercareasusual.Therefore,useofpharmacologic
and nonpharmacologic treatments for painwas permitted.
Statistical Analysis
The goal of the analysis was to detect a moderate treatment
effect size. We defined a moderate effect size as an SD of 0.4
or 1.8 change points on the RMDS score at 9 months. With a
1:1 treatment allocation and allowance formore than 15% loss
to follow-up, we enrolled 121 patients per group to ensure at
least 100 patients per group for the desired power of 80%and
significance of .05 (2-tailed) for the analyses.
Baselinecharacteristicsofpatientswere reported,withcat-
egorical variables as frequencies (percentages) and continu-
ous variables as means (SDs). The primary end point com-
pared the change from baseline to 9 months between study
groups. We used the intention-to-treat principle and in-
cluded all randomized patients in the analysis. Mixed-effect
models with repeated measurements were used as the pri-
mary analysis. Change from baseline to each follow-up visit
constituted the responsevariable, and treatmentgroups, visit,
and their interaction were the main predictors and were ad-
justed for the baseline value of the outcomemeasure. A ran-
dom intercept was included tomodel within-participant cor-
relation. The intervention effect was evaluated based on the
mixed-effect models with repeated measurements analysis.
In addition,wepresent summary statistics (mean [SD]) of out-
come measurements at baseline and at the 9-month assess-
ment by treatment group. A 2-sample t test was used to com-
pare the difference of change from baseline to 9 months.
Weevaluatedthesensitivityofouranalysis tomissingdata.
We found no difference in the magnitude of missing data be-
tween study arms, andnoneof the outcomevariables at base-
line was associated with the probability of missing. We used
complete cases and the last observation carried forward and
obtainedsimilar results.Therefore,we report resultsof thepri-
mary analysis based on the mixed-effect models with re-
peated measurements. The profiles of outcome measure-
ments during the 9-month follow-up were also summarized
bymeans and 95% CIs at each visit. A clinically important re-
sponse forRMDSscores (>30%decrease) at 9monthswas ana-
lyzed using a log-binomial model (SAS GENMOD procedure
with log link function)35 for calculating relative risk. Analyses
were conducted using commercially available software (SAS,
version 9.3; SAS Institute Inc).
Results
Participant Flow
Figure 1 details participant enrollment and follow-up in the
trial. Of the 659 patients initially undergoing assessment, 272
were ineligible, most often because they did not report pain
or have at least moderately limiting pain (ie, RMDS score <7
Figure 1. Flowchart of Participants in the Evaluation of Stepped Care
for Chronic Pain (ESCAPE) Trial in Veterans of the Afghanistan
and Iraq Conflicts
417 Excluded
97 Pain not functionally limiting
33 Potential substance/alcohol issue
61 Not OEF/OIF veteran
5 No longer treated at VA
8 Pain location ineligible
2 Pregnant
3 Had schizophrenia
1 No phone
108 Not interested (but eligible)
37 Scheduled but did not keep
appointment
31 No pain
31 Previous back surgery
3-mo Interview
106 Assessed
9 Withdrew
6 Unable to contact
3-mo Interview
112 Assessed
4 Withdrew
4 Unable to contact
9-mo Interview
108 Assessed
11 Withdrew
2 Unable to contact
9-mo Interview
114 Assessed
6 Withdrew
0 Unable to contact
6-mo Interview
96 Assessed
11 Withdrew
14 Unable to contact
6-mo Interview
110 Assessed
5 Withdrew
5 Unable to contact
659 Patients assessed for
the ESCAPE trial
121 Included in the primary
analysis
120 Included in the primary
analysis
121 Randomized to stepped-
care intervention
120 Randomized to usual
care
241 Completed baseline
interviews and were
randomized
OEF/OIF indicates Operation Enduring Freedom/Operation Iraqi Freedom;
VA, Veterans Affairs.
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[n = 128]).Of the387eligiblepatients, 242 (62.5%)enrolled.One
participant consented, enrolled, and completed abaseline as-
sessment.However, after being randomized tousual care, the
participant immediatelywithdrew and requested that the as-
sessment be destroyed and not included in the study, leaving
241 patients with baseline data.
Baseline Characteristics of Study Sample
Baseline characteristics are shown in Table 2. The mean age
of patientswas 36.7 (range, 21-73) years, and88.4%weremen.
In termsof racialmix, 77.7%werewhite, 13.0%wereblack, and
9.2%classified asother (3patients refused to answer). Thepri-
marysiteofpainwas the lowback (57.3%) followedby theknee
(21.6%),neck (7.5%), shoulder (7.1%), andhip (6.6%).More than
two-thirds of the patients (66.4%) had served in the Army,
74.9% had been deployed to Iraq, 8.8% had been deployed to
Afghanistan, and 16.3% had been deployed to both conflicts
(information was missing for 2 patients).
As shown in Table 3, the stepped-care intervention and
usual care groups had similar baseline pain measures. The
meanRMDS score of 13.9 (range, 0-24) representsmoderately
severepain–relateddisability. Likewise, themeanBPI Pain In-
terference subscale score of 5.4 (range, 0-10) representsmod-
erately severe interferencewithactivities becauseofpain, and
ameanGradedChronicPainScale severity scoreof66.2 (range,
0-100) signifies moderate pain intensity.
At 9 months, overall follow-up completion was 91.7%
(89.3% for the interventiongroupand94.2% for theusual care
group), with no significant differences between groups. Pa-
tients lost toorunavailable for follow-updidnotdifferonbase-
line characteristics fromthosewhoprovideddata at 9months.
Themost frequentlycitedreasonforwithdrawal fromthestudy
was lack of time.
Primary Study Outcomes
The primary analysis included 121 patients in the interven-
tion group and 120 in the usual care group. Compared with
usual care, the intervention led to significant improvements
in all pain outcomes at 9 months (Table 3 and Figure 2). The
RMDSscoredecreasedby 1.7 (95%CI, −2.6 to−0.9) points from
baseline to 9 months in the usual care group and by 3.7 (95%
CI, −4.5 to −2.8) points in the intervention group (between-
group difference, −1.9 [95%CI, −3.2 to −0.7] points; P = .002).
Patients in the intervention group were more likely to dem-
onstrate at least a 30% improvement in RMDS scores by 9
months (relative risk, 1.52 [95% CI, 1.22-1.99]; P < .001), with
a number needed to treat of 7.5 for 30% improvement.
The mean decrease in the BPI Pain Interference subscale
score was 0.9 (95% CI, −1.2 to −0.5) points in the usual care
group and 1.7 (95% CI, −2.1 to −1.3) points in the intervention
group (between-group difference, −0.8 [95% CI, −1.3 to −0.3]
points;P = .003). TheGradedChronicPainScale severity score
was reduced by 4.5 (95% CI, −7.3 to −1.8) points in the usual
care group and 11.1 (95% CI, −13.9 to −8.3) points in the inter-
ventiongroup (between-groupdifference, −6.6 [95%CI, −10.5
to−2.7] points;P = .001). Figure 2 illustrates the significant in-
tervention effect on pain-related disability (RMDS score), BPI
Pain Interferencesubscalescore,andGradedChronicPainScale
severity score throughout the9-month trial.Althoughall 3pain
outcomes significantly improved, the reduction inpain sever-
itywasmoremodest than those for pain-relateddisability and
pain interference.
Analgesic Use and Self-management Strategies
Wedeterminedanalgesicuseduring the trial by self-report and
electronic health record query. Treatment groups were simi-
lar at baseline in analgesicuse (eTable inSupplement 2).At the
endof step 1 (3months), patients in the intervention group re-
ceivedmoreagents ineachanalgesic class relative towhat they
were prescribed at baseline. However, at the study end
Table 2. Baseline Characteristics of 241 Patients in the ESCAPE Study
Baseline Characteristic
Study Groupa
Stepped Care
(n = 121)
Usual Care
(n = 120)
Age, mean (SD), y 36.4 (10.1) 38.2 (10.5)
Men 109 (90.1) 104 (86.7)
Raceb
White 93 (78.2) 92 (77.3)
Black 16 (13.4) 15 (12.6)
Other 10 (8.4) 12 (10.1)
Educational levelc
High school 27 (22.5) 31 (25.8)
>High school 93 (77.5) 89 (74.2)
Married 72 (59.5) 65 (54.2)
Income “just enough”
to make ends meet
55 (45.5) 53 (44.2)
Employment statusc
Employed 73 (60.3) 73 (61.3)
Student 20 (16.5) 10 (8.4)
Unemployed or unable to work 28 (23.1) 36 (30.3)
Pain location
Back 64 (52.9) 74 (61.7)
Knee 28 (23.1) 24 (20.0)
Neck 10 (8.3) 8 (6.7)
Shoulder 10 (8.3) 7 (5.8)
Hip 9 (7.4) 7 (5.8)
Served in Army 83 (68.6) 77 (64.2)
Deployment
Iraq 94 (77.7) 85 (72.0)
Afghanistan 8 (6.6) 13 (11.0)
Both 19 (15.7) 20 (16.9)
No. of medical diseases, mean (SD) 0.86 (0.95) 1.03 (1.01)
PTSD symptom score, mean (SD)d 27.6 (19.2) 25.2 (19.7)
Depression score, mean (SD)e 11.1 (6.2) 11.3 (5.6)
Abbreviation: ESCAPE, Evaluation of Stepped Care for Chronic Pain.
a Data are presented as number (percentage) unless otherwise indicated.
b Information wasmissing for 3 patients.
c Information wasmissing for 1 patient.
dDetermined using the Posttraumatic Stress Disorder Check List–17.36 Scores
range from0 to 68, with higher scores representing more severe
posttraumatic stress disorder symptoms.
e Determined using Patient Health Questionnaire–9.37 Scores range from0 to
27, with higher scores representing more severe depression.
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(9 months), those patients were using more topical analge-
sics and patients in the usual care group receivedmore tricy-
clic antidepressants.
Self-management Strategies, CBT,
and Intervention Adherence
The intervention group had a mean of 5.6 (median, 6) tele-
phone sessionswithNCMsduring step 1 to discuss analgesics
and self-management strategies. Patients were taught sev-
eral strategies, including tips about physical activity (96 pa-
tients [79.3%]), pain education (92 [76.0%]), alternative think-
ing (72 [59.5%]), stress management (66 [54.5%]), effective
communication (32 [26.4%]), and community resources (21
[17.4%]). In step 2, themeannumber of CBT sessions inwhich
patients participatedwas 3.6 (median, 5). In total, patients re-
ceived a mean of 9.2 (median, 12) NCM contacts during the
9-month study period.
Discussion
The stepped-care intervention targetedmusculoskeletal pain
because it is themost common,disabling, andcostlyof all pain
conditions.38,39 The functional and economic effect of mus-
culoskeletal pain on military personnel40 is substantial. We
found that an intervention combining analgesics, self-
management strategies, andCBT is effective in reducingpain-
related disability, pain interference, and pain severity inOEF/
OIF/ONDveteranswithchronic,disablingmusculoskeletalpain
of the spine and extremities.
Table 3. Baseline, 9-Month Follow-up, and Change in Pain Outcomes in ESCAPE Trial Participants
Outcome
Pain Outcomes
Stepped-Care Group
(n = 121)
Usual Care Group
(n = 120)
Between-Group Difference
(95% CI) P Value
RMDS Score (Range, 0-24)
Baselinea 14.0 (4.3) 13.7 (4.7) NA .62
9-mo Follow-upa 10.6 (6.3) 12.1 (6.4) NA .09
Change from baseline, mean (95% CI)b −3.7 (−4.5 to −2.8) −1.7 (−2.6 to −0.9) −1.9 (−3.2 to −0.7) .002
BPI Pain Interference Subscale Score (Range, 0-10)
Baselinea 5.4 (2.1) 5.4 (2.4) NA .86
9-mo Follow-upa 3.8 (2.6) 4.5 (2.7) NA .03
Change from baseline, mean (95% CI)b −1.7 (−2.1 to −1.3) −0.9 (−1.2 to −0.05) −0.8 (−1.3 to −0.3) .003
GCPS Severity Score (Range, 0-100)c
Baselinea 67.3 (12.1) 65.1 (15.2) NA .22
9-mo Follow-upa 56.9 (19.1) 61.0 (19.3) NA .09
Change from baseline, mean (95% CI)b −11.1 (−13.9 to −8.3) −4.5 (−7.3 to −1.8) −6.6 (−10.5 to −2.7) .001
Abbreviations: BPI, Brief Pain Inventory; ESCAPE, Evaluation of Stepped Care
for Chronic Pain; GCPS, Graded Chronic Pain Scale; NA, not applicable;
RMDS, RolandMorris Disability Scale.
a Summary statistics by group and P value are based on the 2-sample t test.
b Estimates based onmixed-effect model with repeatedmeasurements. Effect
sizes are 0.24 for the RMDS, 0.26 for the BPI Pain Interference subscale, and
0.21 for GCPS severity.
c Denotes greater disability, pain interference, and pain severity scores.
Figure 2. Pain Outcomes
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Outcomes were assessed at baseline and at months 3, 6, and 9 follow-up.
A, Pain-related disability was measured by the RolandMorris Disability Scale.
Scores range from0 to 24, with higher scores representing more severe
pain-related disability. B, Pain interference wasmeasured by the Pain
Interference subscale total score of the Brief Pain Inventory (BPI). Seven items
are scored with a range from0 to 10, with themean calculated for the total
score and a decrease considered improvement. C, Pain severity was measured
by the Graded Chronic Pain Scale (GCPS). Scores range from0 to 100, with
higher scores representing more severe pain. Because we used the
intention-to-treat principle, all randomized patients were included in the
analysis. Substantial reduction was seen in all 3 measures during the 9-month
trial among patients in the intervention group. A total of 11 patients withdrew
from the intervention arm and 6 patients from the usual care arm. Error bars
indicate 95% CIs.
Research Original Investigation ESCAPE in Veterans
E6 JAMA Internal Medicine Published onlineMarch 9, 2015 (Reprinted) jamainternalmedicine.com
Downloaded From: http://archinte.jamanetwork.com/ on 03/26/2015
Copyright 2015 American Medical Association. All rights reserved.
The ESCAPE trial was designed and implemented within
a large VAhealth care system.We believe that the ESCAPE in-
terventiongeneralizes especiallywell tootherVAmedical cen-
ters and other large health care systems outside the VA.How-
ever, implementing the approach to smaller community
settings or to private settings may be challenging.
Our study adds to the literature about multimodal ap-
proaches that combine pharmacologic and nonpharmaco-
logic treatments thatmay be applied in nonspecialty settings.
Studyfindingshave implications for thepatient-centeredmedi-
cal home environment, especially an emphasis on team-
based care. This study also demonstrates a potential model
of sequencing pain treatments involving analgesics, self-
management strategies, and CBT.
Patients in the ESCAPE intervention experienced a 3.7-
point reduction in RMDS scores, which is clinically signifi-
cant for individual patients.41 Although between-group dif-
ferences for the intervention and usual care did not meet a
2-point difference, thismetric to defineminimally important
change is more appropriately applied to individual differ-
ences rather than group differences.41 Findings from the
ESCAPEtrial are consistentwith those in3previous trials31,42,43
usingacaremanagement–basedapproach.Kroenkeetal31 com-
bined antidepressantswith a pain self-management program
in patients with comorbid musculoskeletal pain and depres-
sion. Patients receiving the intervention showed substantial
improvements in depression and a significant decrease of 3.3
points in the RMDS score comparedwith usual care. Dobscha
and colleagues42 evaluated a collaborative care intervention
in veterans with chronic pain. The intervention was deliv-
ered by a clinical psychologist rather thannurses and showed
that patients improvedonpain disability (theRMDS score de-
creasedby 1.4points).42A recent trial byKroenkeet al43 found
that significantlymoreprimarycarepatientswithchronicpain
improved because of an intervention that used automated
symptom monitoring and NCMs to optimize use of non-
opioid analgesics.43
The ESCAPE trial has some limitations. First, partici-
pants were all recent veterans with chronic musculoskeletal
pain; our results may not apply to veterans from other eras
or to nonveterans. Second, the trial was conducted at a
single medical center. Single-center, randomized clinical
trials have shown larger treatment effects than multicenter
trials.44 However, the intervention effects observed were
comparable to other interventions tested at more than 1 site.
Third, the ESCAPE trial tested a multimodal intervention
and used a bundled approach to delivery. As a result, we
were not able to determine the relative efficacy of interven-
tion components and were unable to separate out atten-
tional effects. However, to help disentangle these effects,
we gathered in-depth, qualitative data from patients in the
intervention group (n = 26) to determine their experiences
with and perceptions of the intervention. The patients
spoke about their evolving understanding of their pain
experience during the trial and how this new understanding
helped them manage their pain more effectively.45,46
Fourth, study patients were not blinded. The major
strengths of our trial include (1) a high-priority patient
population (OEF/OIF/OND veterans) with complex pain care
needs, (2) an innovative approach that challenges existing
treatment paradigms for chronic pain, and (3) a telephone-
based intervention delivered by NCMs that may be applied
across multiple geographically dispersed clinical settings.
Conclusions
A stepped-care intervention that combined analgesics, self-
management strategies, and CBT benefited OEF/OIF/OND
veterans with chronic musculoskeletal pain in terms of
pain-related disability, pain interference, and pain severity.
Additional pain treatments will need to be combined in a
stepped-care model to produce even greater improvements
in pain.
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